CCL2 and neoplasm: Therefore, the authors concluded that tumour induced factors led to the low HLA-DR expression in the monocyte phenotype, however, Dex reduced CCL2 secretion by the tumour, reducing tumour recruitment of monocytes and resulting in increased peripheral CD14+HLA-DR−/lo monocytes [124].